1-5 of 5
Stuart McGurnaghan
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Relation of Incident Type 1 Diabetes to Recent COVID-19 Infection: Cohort Study Using e-Health Record Linkage in Scotland

Paul M. McKeigue, Stuart McGurnaghan, Luke Blackbourn, Louise E. Bath, David A. McAllister, Thomas M. Caparrotta, Sarah H. Wild, Simon N. Wood, Diane Stockton, Helen M. Colhoun
Journal: Diabetes Care
Diabetes Care 2023;46(5):921–928
DOI: https://doi.org/10.2337/dc22-0385
Published: 26 July 2023
View article titled, Relation of Incident Type 1 Diabetes to Recent COVID-19 Infection: Cohort Study Using e-Health Record Linkage in Scotland
Open the PDF for Relation of Incident Type 1 Diabetes to Recent COVID-19 Infection: Cohort Study Using e-Health Record Linkage in Scotland in another window
Journal Articles

Cardiovascular Safety in Type 2 Diabetes With Sulfonylureas as Second-line Drugs: A Nationwide Population-Based Comparative Safety Study

Huan Wang, Ruth L.M. Cordiner, Yu Huang, Louise Donnelly, Simona Hapca, Andrew Collier, John McKnight, Brian Kennon, Fraser Gibb, Paul McKeigue, Sarah H. Wild, Helen Colhoun, John Chalmers, John Petrie, Naveed Sattar, Thomas MacDonald, Rory J. McCrimmon, Daniel R. Morales, Ewan R. Pearson, Scottish Diabetes Research Network Epidemiology Group , Luke Blackbourn, Scott Cunningham, Fraser Gibb, Graham Leese, Robert Lindsay, David McAllister, Stuart McGurnaghan, Sam Philip
Journal: Diabetes Care
Diabetes Care 2023;46(5):967–977
DOI: https://doi.org/10.2337/dc22-1238
Published: 21 March 2023
View article titled, Cardiovascular Safety in Type 2 Diabetes With Sulfonylureas as Second-line Drugs: A Nationwide Population-Based Comparative Safety Study
Open the PDF for Cardiovascular Safety in Type 2 Diabetes With Sulfonylureas as Second-line Drugs: A Nationwide Population-Based Comparative Safety Study in another window
Journal Articles

Erratum. Clinical Impact of Residual C-Peptide Secretion in Type 1 Diabetes on Glycemia and Microvascular Complications. Diabetes Care 2021;44: 390–398

Anita Jeyam, Helen Colhoun, Stuart McGurnaghan, Luke Blackbourn, Timothy J. McDonald, Colin N.A. Palmer, John A. McKnight, Mark W.J. Strachan, Alan W. Patrick, John Chalmers, Robert S. Lindsay, John R. Petrie, Sandeep Thekkepat, Andrew Collier, Sandra MacRury, Paul M. McKeigue
Journal: Diabetes Care
Diabetes Care 2021;44(4):1072
DOI: https://doi.org/10.2337/dc21-er04b
Published: 27 January 2021
View article titled, Erratum. Clinical Impact of Residual C-Peptide Secretion in Type 1 Diabetes on Glycemia and Microvascular Complications. Diabetes Care 2021;44: 390–398
Open the PDF for Erratum. Clinical Impact of Residual C-Peptide Secretion in Type 1 Diabetes on Glycemia and Microvascular Complications. Diabetes Care 2021;44: 390–398 in another window
Journal Articles

Clinical Impact of Residual C-Peptide Secretion in Type 1 Diabetes on Glycemia and Microvascular Complications

Anita Jeyam, Helen Colhoun, Stuart McGurnaghan, Luke Blackbourn, Timothy J. McDonald, Colin N.A. Palmer, John A. McKnight, Mark W.J. Strachan, Alan W. Patrick, John Chalmers, Robert S. Lindsay, John R. Petrie, Sandeep Thekkepat, Andrew Collier, Sandra MacRury, Paul M. McKeigue
Journal: Diabetes Care
Diabetes Care 2021;44(2):390–398
DOI: https://doi.org/10.2337/dc20-0567
Published: 10 December 2020
View article titled, Clinical Impact of Residual C-Peptide Secretion in Type 1 Diabetes on Glycemia and Microvascular Complications
Open the PDF for Clinical Impact of Residual C-Peptide Secretion in Type 1 Diabetes on Glycemia and Microvascular Complications in another window
Journal Articles

Cardiovascular Disease, Cancer, and Mortality Among People With Type 2 Diabetes and Alcoholic or Nonalcoholic Fatty Liver Disease Hospital Admission

Sarah H. Wild, Jeremy J. Walker, Joanne R. Morling, David A. McAllister, Helen M. Colhoun, Bassam Farran, Stuart McGurnaghan, Rory McCrimmon, Stephanie H. Read, Naveed Sattar, Christopher D. Byrne, Scottish Diabetes Research Network Epidemiology Group, Sarah H. Wild, Jeremy J. Walker, Joanne R. Morling, David A. McAllister, Helen Colhoun, Bassam Farran, Stuart McGurnaghan, Rory McCrimmon, Stephanie H. Read, Naveed Sattar, Christopher D. Byrne, Robert Lindsay, Graham Leese, John McKnight, John Petrie, John Chalmers, Colin Fischbacher, Scott Cunningham, Olivia Wu, Sam Philip
Journal: Diabetes Care
Diabetes Care 2018;41(2):341–347
DOI: https://doi.org/10.2337/dc17-1590
Published: 22 November 2017
View article titled, Cardiovascular Disease, Cancer, and Mortality Among People With Type 2 Diabetes and Alcoholic or Nonalcoholic Fatty Liver Disease Hospital Admission
Open the PDF for Cardiovascular Disease, Cancer, and Mortality Among People With Type 2 Diabetes and Alcoholic or Nonalcoholic Fatty Liver Disease Hospital Admission in another window
Includes: Supplementary data